|
Glaucoma Physician Testimonials Nathan Radcliffe, MD New York Eye Surgery Center
Bronx, NY USA | | Michael Giovingo, MD Cook County Health and Hospital System
Chicago, IL | | Takashi Fujishiro, MD University of Tokyo Hospital
Tokyo, Japan | | Jonathan S. Myers, MD Wills Eye Hospital
Philadelphia, PA USA | | Cristobal Cruz Colon, MD Center for Excellence in Eye Care
Miami, FL USA | | Nathan Radcliffe, MD New York Eye Surgery Center
Bronx, NY USA | | Jella An, MD Glaucoma Specialist
University of Missouri | | Sandra Sieminski, MD Director of Glaucoma
Ross Eye Institute
Buffalo, NY USA | | Shan Lin, MD Director of Glaucoma Service
UCSF
San Francisco, CA USA | | David Gossage, DO, FAOCO, FAAO Gossage Eye Institute
Hillsdale, MI USA | | | "I was using the Cyclo G6 glaucoma laser for refractory glaucoma patients, but as I saw the results and how comfortable the patients were, I started to expand its use, and now I use it for various types of glaucoma cases." Sandra Fernando Sieminski, MD
Ross Eye Institute
Buffalo, NY USA | "Numerous published studies and clinical experience in the US, Europe and Asia over the last several years have demonstrated that it is a safe and effective option to decrease both IOP and the number of topical medications necessary in many glaucoma patients. I regularly treat a wide variety of glaucoma patients with it, and my patients are very happy with the results." Ahad Mahootchi, MD
The Eye Clinic of Florida
Zephyrhills, FL USA | "MicroPulse transscleral cyclophotocoagulation (MP-TSCPC) from IRIDEX has become an irreplaceable tool in my daily practice. It has allowed me to better individualize the care of my glaucoma patients, minimizing risks and allowing for clinical success even in challenging scenarios where I used to have none or few and risky treatment options. It is an evolving technology, and as we continue to learn more about it, we will unveil its full potential." Prof. Tomas M. Grippo, MD
Grippo Glaucoma Center
Buenos Aires, Argentina | | "The MicroPulse P3 Device has given me over 30% IOP lowering. With patients that are non-compliant with their medication, or we are really trying to keep off their medication, the MicroPulse P3 device allows me to treat patients more aggressively" Steven Vold, MD
Vold Vision
Fayetteville, AR USA | "The G-Probe Illuminate is a great new tool for my complex glaucoma cases! It helps me to deliver targeted cyclophotocoagulation treatment with increased visualization of the ciliary body and surrounding working areas and allows me to treat my patients with precise accuracy to the desired tissue, especially in patients with abnormal anatomy." Marc Töteberg-Harms, MD, FEBO
University Hospital Zurich
Switzerland | "MicroPulse mode allows me to treat transfoveally, so it can treat conditions that other lasers can’t, such as central serous retinopathy (CSR), wet AMD, or pseudophakic CME. I routinely use MicroPulse for DME and glaucoma as well." Ahad Mahootchi, MD
The Eye Clinic of Florida
Zephyrhills, FL USA | | “I have been using the MicroPulse Transscleral Cyclophotocoagulation (MP-TSCPC) procedure with the Cyclo G6 glaucoma laser and the MicroPulse P3 probe in my practice for more than 2 years. MicroPulse mode has proven to be an efficacious choice for many of my glaucoma patients, with significant reduction in pressure and medication use for most. I have found that after MP-TSCPC procedures, my patients experience less pain and less post-procedural inflammation than after traditional CPC.” Jonathan S. Myers, MD
Director of the Glaucoma Service
Wills Eye Hospital | “Since 2016, I have loved having IRIDEX‘s Cyclo G6 Laser in my surgical toolbox for many types of glaucoma, including those in late stage and refractory stages. I am a big fan because this can often save someone from incisional surgery. Of course, selecting the right patient is key to ensure good outcomes and minimal side effects.” Monisha Vora, MD
Glaucoma Specialist
Wills Eye Hospital | “In a study that I performed with 71 eyes of 68 patients, I found that MicroPulse Transscleral Laser Therapy demonstrated good efficacy and safety profiles with minimal vision-threatening complications in treating a variety of glaucoma types.” Ahmed Al Habash, MD
Glaucoma Specialist
Imam Abdulrahman Bin Faisal University
Saudi Arabia | Retina Physician Testimonials Munir Escaf, MD Retina Specialist
Clinica Carriazo Barranquilla
Atlantico, Columbia | | Jonathan Feistman, MD Retina Specialist
NYC Retina
New York City, NY | | Brian Horsman, MD Director, Retina Group
Barnet Dulaney Perkins Eye Center
Phoenix, AZ USA | | Brandon Johnson, MD NYC Retina
New York, NY USA | | Ahad Mahootchi, MD Medical Director
The Eye Clinic of Florida
Zephyrhills, FL | | Walid Mangal, DO Florida Vision Institute
Stuart, FL USA | | | "By incorporating MicroPulse, my injection burden decreases by one-third at a minimum, which is a conservative estimate. The versatility of MicroPulse to treat retinal disorders and glaucoma allows me to provide my patients with a treatment that’s clinically effective, cost effective, and time effective.""MLT is both safe and durable. This therapy can be considered a first-line treatment for glaucoma patients, as well as patients who haven’t seen significant effects from medications." Jason Friedrichs, MD, MS
Friedrichs Eye
Sycamore, IL USA | "Compared to other lasers, the IQ 532 Laser with the MicroPulse module offers greater versatility because it can also be used for a range of other conditions including diabetic macular edema, proliferative diabetic retinopathy, and retinal tears. I'm comfortable offering MLT to glaucoma patients as a first-line option because of its potential to reduce intraocular pressure without causing tissue damage." David Gossage, DO, FAOCO, FAAO
Gossage Eye Institute
Hillsdale, MI USA | "The MicroPulse P3 Device has become an essential part of my armamentarium for use in glaucoma surgical procedures. It provides a very safe and efficacious solution for IOP control. I have used MicroPulse P3 for some of my most complicated cases but also I feel comfortable enough using it for patients with earlier disease in which we want to avoid a filtering bleb or the placement of hardware in the eye." Robert Noecker, MD, MBA
Ophthalmic Consultants of Connecticut
Fairfield, CT USA | | "...treatment is less difficult and often takes less time than 532 nm." Dr. John T. Harriott
Winston-Salem, NC | | “The IQ532 Tx Cell Laser System is an invaluable adjunct in my armamentarium for a growing multitude of retinal and choroidal pathologies. In my hands, micropulse laser technology has achieved significant anatomic and functional gains as primary and combination therapy. The TxCell pattern delivery dramatically increases laser application efficiency, as well as patient comfort.” Caesar Luo, MD
Bay Area Retina Associates
Oakland, CA USA | | "I have found the MicroPulse P3 Device to be a non-incisional, easy, and safe way to reduce pressure anytime my patients need it, and it is predictable and highly efficacious." Melissa Toyos, MD
Toyos Clinic
Nashville, TN USA | "MLT is both safe and durable. This therapy can be considered a first-line treatment for glaucoma patients, as well as patients who haven’t seen significant effects from medications." Ike Ahmed, MD, FRCSC
Prism Eye Institute
Toronto, Ontario, Canada | "I have been impressed that the MicroPulse P3 therapy with the Cyclo G6 Glaucoma Laser can deliver pressure lowering in a broad range of glaucomas, including mild and moderate patients who I want to free from the adverse effects of drops." Rolando Toyos, MD
Toyos Clinic
Nashville, TN USA | | "The visualization of the ciliary body and the surrounding area is impressive. It has really helped me to deliver a patient-specific, targeted CPC treatment with an easy-to-use probe." Steven Vold, MD
Vold Vision
Fayetteville, AR USA | | "You can really consider TSCPC in almost all glaucoma situation, even malignant glaucoma. It is not just relegated to end-stage treatment anymore." Dr. Jeffrey Kammer
Vanderbilt Eye Institute
Nashville, TN | "TSCPC is a surgery that can be done before or after any other surgery. It is very versatile from that standpoint. " Nathan Radcliffe, MD
New York Eye Surgery Center
Bronx, NY USA | "Recovery with TSCPC is much more rapid and the postoperative care much less involved than with someone who has had an incisional glaucoma case in a surgical center." Steven Vold, MD
Vold Vision
Fayetteville, AR USA | Lawrence Morse, MD, PhD UC Davis
Davis, CA USA | | Kishiko Ohkoshi, MD Professor, Director, Chief Vitreoretinal Surgeon
St. Luke’s International University
Tokyo, Japan | | Julia Schulman, MD NYC Retina
New York, NY USA | | Stela Vujosevic, MD Professor, Medial Retina Specialist
University Hospital Maggiore della Carita
Novara, Italy | | Glenn Yiu, MD, PhD UC Davis
Davis, CA USA | | Marco Zarbin, MD, PhD, FACS Rutgers New Jersey Medical School
Newark, NJ USA | | MLT Focused | "I achieved such good results with MLT that I decided to try MicroPulse for treating retinal diseases. I now use it daily to treat many retinal disorders, and MicroPulse allows me to treat patients who I could not have otherwise." Brandon Philips, MD
Carolina Vision Center
Fayetteville, NC USA | "MLT is versatile in variety of ways: for patients just starting therapy, replacing an eye drop, as an adjunct to an eye drop or to keep them away from incisional surgery." Nathan Radcliffe, MD
New York Eye Surgery Center
Bronx, NY USA | "The IQ 577 Laser produces less collateral damage than a traditional green-wavelength laser during the treatment of macular edema. It's more efficient and increases patient comfort for panretinal photocoagulation." Jonathan Walker, MD
Lutheran Hospital of Indiana
Fort Wayne, IN USA | | "The IQ 577 Laser System has simplified and improved the efficiency of laser clinics dramatically." Christopher Riemann, MD
Cincinnati Eye Institute
Cincinnati, OH USA | "The IQ 577 Laser System with yellow laser is one such promising advancement for the treatment of macular edema." Sviatoslav Suk, MD, PhD
Eye Microsurgery Center
Kiev, Ukraine | | "At Veterinary Vision we frequently use the diode laser from IRIDEX for treating a variety of conditions including uveal, limbal and eyelid melanomas, and iris cysts. There are many delivery systems available, including the operating microscope adapter (OMA), retinopexy, EndoProbe and transscleral probes, allowing the laser to be delivered in both contact and non contact modes. Diode laser treatment for glaucoma includes transscleral and endo cyclophotocoagulation techniques offering some of the best options available for treating this challenging condition." Cynthia Cook, DVM, PhD, Diplomate ACVO
Veterinary Vision, Inc
San Carlos and San Francisco, CA USA | "Recent availability of the Cyclo G6 Glaucoma Laser System offers another modality for reducing aqueous production as a treatment for glaucoma. MicroPulse technology has the potential to achieve optimal cyclodestructive effects with much less inflammation and potential for damaging postoperative intraocular pressure spikes. We are fortunate to be among the veterinary centers beginning to accumulate data using this novel technology." Cynthia Cook, DVM, PhD, Diplomate ACVO
Veterinary Vision, Inc
San Carlos and San Francisco, CA USA |
|
|
|
|
|
|
|
|
|
|
|